Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-17
DOI
10.1038/srep37234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis
- (2016) Hailiang Liu et al. JOURNAL OF LIPID RESEARCH
- Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
- (2016) Vivette D. D'Agati et al. Nature Reviews Nephrology
- Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways
- (2016) Bi Chen et al. RESPIROLOGY
- FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
- (2016) Len Verbeke et al. Scientific Reports
- Role of Smad signaling in kidney disease
- (2015) Yanhua Zhang et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction
- (2015) Xinli Qu et al. KIDNEY INTERNATIONAL
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts
- (2015) Jiamei Lu et al. LIFE SCIENCES
- Regulation of Renal Fibrosis by Smad3 Thr388 Phosphorylation
- (2014) Xinli Qu et al. AMERICAN JOURNAL OF PATHOLOGY
- Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis
- (2014) Weibin Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epidermal growth factor inhibits transforming growth factor-β-induced fibrogenic differentiation marker expression through ERK activation
- (2014) Xiaoying Liu et al. CELLULAR SIGNALLING
- Redox control of p53 in the transcriptional regulation of TGF-β1 target genes through SMAD cooperativity
- (2014) Jessica M. Overstreet et al. CELLULAR SIGNALLING
- Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling
- (2014) Xiwu Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- The Effect of Stachydrine on the Expression of Caspase-12 in Rats with Unilateral Ureteral Obstruction
- (2014) Cui Zhang et al. JOURNAL OF UROLOGY
- Smad3 signaling activates bone marrow-derived fibroblasts in renal fibrosis
- (2014) Jiyuan Chen et al. LABORATORY INVESTIGATION
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- FXR ligands protect against hepatocellular inflammation via SOCS3 induction
- (2012) Zhizhen Xu et al. CELLULAR SIGNALLING
- Role of the TGF-β/BMP-7/Smad pathways in renal diseases
- (2012) Xiao-Ming Meng et al. CLINICAL SCIENCE
- Effect of Chenodeoxycholic Acid on Fibrosis, Inflammation and Oxidative Stress in Kidney in High-Fructose-Fed Wistar Rats
- (2012) Zhijuan Hu et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Nuclear receptors in renal disease
- (2011) Moshe Levi BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro
- (2011) Xiao-Ming Meng et al. KIDNEY INTERNATIONAL
- Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
- (2010) X. X. Wang et al. DIABETES
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Bile acids: Trying to understand their chemistry and biology with the hope of helping patients
- (2008) Alan F. Hofmann HEPATOLOGY
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
- Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade
- (2008) Shan Chen et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started